Differential Effects of Progestogens Used for Menopausal Hormone Therapy

Clin Obstet Gynecol. 2018 Sep;61(3):454-462. doi: 10.1097/GRF.0000000000000364.

Abstract

Recommendations regarding menopausal hormone therapy continue to evolve as more studies are completed. Progestogens, indicated for endometrial protection in women on estrogen therapy who have an intact uterus, seem to confer greater health risks than estrogen alone. Thus, it is important for clinicians to be well informed when prescribing these medications. This review focuses on the different types and use of progestogens in women with an intact uterus using systemic menopausal hormone therapy.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / chemically induced
  • Carbohydrate Metabolism / drug effects
  • Cardiovascular Diseases / prevention & control
  • Carotid Intima-Media Thickness
  • Female
  • Hormone Replacement Therapy* / adverse effects
  • Humans
  • Indoles / pharmacology
  • Indoles / therapeutic use
  • Lipids / blood
  • Menopause / physiology*
  • Progestins / pharmacology
  • Progestins / therapeutic use
  • Selective Estrogen Receptor Modulators / pharmacology
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Stroke / chemically induced
  • Stroke / prevention & control
  • Thromboembolism / chemically induced

Substances

  • Indoles
  • Lipids
  • Progestins
  • Selective Estrogen Receptor Modulators
  • bazedoxifene